![]() However, cell line development with single cell cloning is time consuming, and aggravated by the time needed to screen for a lead clone based on cell line stability and manufacturability. Historically, both toxicology and first-in-human clinical materials are generated using the same clonal-derived cells to ensure safety and minimize any development risks. ![]() ![]() The importance of speed to clinic for medicines that may address unmet medical needs puts pressure on product development timelines.
0 Comments
Leave a Reply. |